Johnson Matthey PLC (JMAT) Insider Buys £392.76 in Stock

Johnson Matthey PLC (LON:JMAT) insider Robert MacLeod purchased 12 shares of the business’s stock in a transaction dated Wednesday, January 17th. The shares were purchased at an average price of GBX 3,273 ($44.39) per share, with a total value of £392.76 ($532.63).

Robert MacLeod also recently made the following trade(s):

  • On Wednesday, November 15th, Robert MacLeod purchased 12 shares of Johnson Matthey stock. The shares were purchased at an average price of GBX 3,304 ($44.81) per share, with a total value of £396.48 ($537.67).

Shares of Johnson Matthey PLC (JMAT) traded up GBX 29 ($0.39) during mid-day trading on Thursday, reaching GBX 3,251 ($44.09). 468,917 shares of the company’s stock traded hands, compared to its average volume of 551,963. The stock has a market cap of $6,290.00 and a PE ratio of 1,711.05. Johnson Matthey PLC has a 52 week low of GBX 2,681 ($36.36) and a 52 week high of GBX 3,511 ($47.61).

Johnson Matthey (LON:JMAT) last released its quarterly earnings data on Tuesday, November 21st. The company reported GBX 99.80 ($1.35) EPS for the quarter, missing analysts’ consensus estimates of GBX 100.10 ($1.36) by GBX (0.30) ($0.00). The company had revenue of GBX 647.83 billion for the quarter. Johnson Matthey had a return on equity of 14.99% and a net margin of 2.60%.

The business also recently disclosed a dividend, which will be paid on Tuesday, February 6th. Investors of record on Thursday, November 30th will be issued a dividend of GBX 21.75 ($0.29) per share. This represents a yield of 0.71%. The ex-dividend date is Thursday, November 30th.

A number of brokerages have recently issued reports on JMAT. Morgan Stanley restated an “overweight” rating and set a GBX 3,500 ($47.46) price target on shares of Johnson Matthey in a report on Sunday, September 24th. Liberum Capital restated a “hold” rating and set a GBX 3,400 ($46.11) price target on shares of Johnson Matthey in a report on Wednesday. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a GBX 3,400 ($46.11) price objective on shares of Johnson Matthey in a research report on Wednesday, November 22nd. Barclays reaffirmed an “overweight” rating and set a GBX 3,680 ($49.91) price objective (up previously from GBX 3,450 ($46.79)) on shares of Johnson Matthey in a research report on Thursday, November 16th. Finally, Berenberg Bank raised shares of Johnson Matthey to a “buy” rating and increased their price objective for the stock from GBX 3,350 ($45.43) to GBX 3,680 ($49.91) in a research report on Friday, January 12th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the company. Johnson Matthey presently has a consensus rating of “Buy” and an average target price of GBX 3,611.30 ($48.97).

COPYRIGHT VIOLATION WARNING: This news story was first published by American Banking News and is the property of of American Banking News. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2018/01/18/johnson-matthey-plc-jmat-insider-buys-392-76-in-stock.html.

About Johnson Matthey

Johnson Matthey Plc is a specialty chemicals company. The Company operates in five divisions: Emission Control Technologies, which is a manufacturer of catalysts and catalyst systems for vehicles and industry; Process Technologies, which is a supplier of catalysts, licensing technologies and other services to the syngas, oleo/biochemical, petrochemical, oil refining and gas processing industries; Precious Metal Products, which is organized into its Services businesses, which include management, distribution, refining and recycling of precious metals, and its Manufacturing businesses, which fabricates products using precious metals or related materials, platinum group metal catalysts and platinum group metal chemicals; Fine Chemicals, which is a supplier of active pharmaceutical ingredients (API), custom services and catalyst technologies, and New Businesses, which focuses on its Battery Technologies, Atmosphere Control Technologies and Fuel Cells Businesses.

Insider Buying and Selling by Quarter for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply